San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Applaud Medical is raising $34,642,571.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Ben Zadik played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Applaud Medical

Applaud, a clinical-stage company based in San Francisco, is committed to improving patient outcomes with innovative new products and procedures built around its SmartSphere technology platform. Two SmartSphere products for urinary stone disease are currently in clinical trials. SmartSphere products are not approved for sale in the United States.

To learn more about Applaud Medical, visit http://applaudmedical.com/

Contact:
Ben Zadik, Chief Financial Officer
415-859-1959

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved